Dr. Philip Barter of the Heart Research Institute of Sydney, Australia, presented an update of the disappointing ILLUMINATE clinical drug trial for the once-promising drug, torcetrapib, at the 2007 American Heart Association meetings in Orlando, Florida.
The crash and burn of drug manufacturer Pfizer's torcetrapib in December 2006 made headlines and prompted enormous disappointment for many patients and doctors who had hoped for a new drug choice to raise HDL cholesterol. Pfizer...
Way back in 1995, doctors in the US and patients with diabetes had a new option to treat type 2 diabetes: a drug of a different kind from... Read more »
Scientists at the University of Liverpool and the Royal Liverpool University Hospital have been awarded £1.4 million––equivalent to... Read more »
Another diabetes drug, dapagliflozin, may soon be available to treat type 2 diabetes. Dapagliflozin is the first in a new class of diabetes... Read more »
On Tuesday, November 18th, the FDA released a warning regarding the use of Prilosec and Prilosec OTC (generic omeprazole) while taking... Read more »
Combination controller inhalers continue to play a vital role in asthma management for many who have a history of moderate to severe... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2013 Remedy Health Media, LLC. All Rights Reserved.
Top 10 Beverages That Lower Your Risk of a Heart Attack 
Foods That Will Help You Reverse Your Heart Disease 
How to Manage Atrial Fibrillation 
Healthy Foods That Get a Bad Rap 
